Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Methyldopa and the erythrocyte membrane

F A Green, C Y Jung, A Rampal

    Clinical and Experimental Immunology
    |June 1, 1980
    PubMed
    Summary

    Alpha-methyldopa tightly binds erythrocyte membrane proteins, especially under oxidative stress. This binding, influenced by hemoglobin and redox agents, may initiate drug-induced hemolytic anemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pictorial review: A Step-by-step Guide to Coronary CT Angiography with Photon-Counting Detector CT.

    The British journal of radiology·2026
    Same author

    Association between Fiber Intake and Risk of Incident Chronic Kidney Disease: The UK Biobank Study.

    The journal of nutrition, health & aging·2023
    Same author

    Optical actuation of a micromechanical photodiode via the photovoltaic-piezoelectric effect.

    Microsystems & nanoengineering·2021
    Same author

    Full-step Class II Correction Using a Modified C-palatal Plate for Total Arch Distalization in an Adolescent.

    The Journal of clinical pediatric dentistry·2018
    Same author

    Permeability of bimolecular membranes made from lipid extracts of human red cell ghosts to sugars.

    The Journal of membrane biology·2013
    Same author

    Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.

    International journal of clinical pharmacology and therapeutics·2008

    Area of Science:

    • Biochemistry
    • Hematology
    • Pharmacology

    Background:

    • Alpha-methyldopa is a medication used to treat high blood pressure.
    • Drug-induced hemolytic anemia is a serious adverse effect associated with some medications.
    • The precise mechanism by which alpha-methyldopa causes hemolytic anemia is not fully understood.

    Purpose of the Study:

    • To investigate the binding characteristics of alpha-methyldopa to human erythrocyte membranes.
    • To explore the influence of oxidative and reductive conditions on this binding.
    • To elucidate the potential role of hemoglobin and membrane proteins in alpha-methyldopa-induced hemolytic anemia.

    Main Methods:

    • Incubation of human erythrocytes with alpha-methyldopa.
    • Analysis of drug binding to membrane proteins using SDS-PAGE and Western blotting.
    • Assessment of binding under varying oxidative and reductive conditions.
    • Competition assays with hemoglobin and membrane peptides.

    Main Results:

    • Alpha-methyldopa exhibits both readily dissociable and tightly bound interactions with erythrocyte membrane proteins.
    • Binding is enhanced under oxidizing conditions and significantly inhibited by reducing agents, superoxide dismutase, and catalase.
    • Hemoglobin competes with membrane peptides for alpha-methyldopa binding.

    Conclusions:

    • Hemoglobin may act as a drug sink within erythrocytes.
    • The tight binding of alpha-methyldopa to critical membrane peptides, particularly during normal cell breakdown, is a potential initiating event in Coombs positivity and hemolytic anemia.

    Related Experiment Videos